top of page

AGENDA

Friday, October 16, 2020

12:50 – 1:00 PM EDT

Welcome/Introduction

​

SESSION I (Vinod Rustgi, MD, MBA)

​

1:00 – 1:30 PM 

Hepatitis C: Expanding Indications, Black Box Warnings and Screening

Vinod Rustgi, MD, MBA*

​

1:30 – 2:00 PM 

NAFLD/NASH: Screening, Current Management and Treatments on the Horizon

David Bernstein, MD*

​

2:00 – 2:55 PM 

Complications of Portal Hypertension: Management Options for Hepatic Encephalopathy, Thrombocytopenia, and Hepatorenal Syndrome

Kimberly Brown, MD and Robert Brown, MD, MPH*

​

2:55 – 3:15 PM 

Q&A / Panel Discussion

​

3:15 – 3:30 PM 

Break

​

SESSION II (David Bernstein, MD)

3:30 – 3:55 PM

Common Dilemmas in the Diagnosis and Management of Drug-Induced Liver Injury 

Ira Jacobson, MD

​

3:55 – 4:25 PM 

Management of Fecal Incontinence 

Baha Moshiree, MD, MS-ci

​

4:25 – 4:50 PM 

Microbiome-Based Treatments for IBS: Food, Bugs or Drugs

William Chey, MD

​

4:50 – 5:15 PM

Q&A / Panel Discussion

​

5:15 – 5:30 PM

Day 1 Wrap-up

​

5:30 – 7:00 PM

Welcome Reception

Saturday, October 17, 2020

7:30 – 8:20 AM EDT

Breakfast

​

8:20 – 8:30 AM

Welcome

​

SESSION III (Robert Brown, MD, MPH)

​

8:30 – 9:00 AM

How Opioid Use Might Impact Esophageal Symptoms and Motility 

Michael Vaezi, MD, PhD, MSc

​

9:00 – 9:30 AM

GERD and Sleep: An Eye-opening Experience

Ronnie Fass, MD

​

9:30 – 10:00 AM

Chronic Pancreatitis

Allison Yang, MD, MPH

​

10:00 – 10:30 AM

Q&A / Panel Discussion

​

10:30 – 10:45 AM

Break

​

10:45 – 11:45 AM

Parallel Sessions (LIVE ONLY)

(Attendees select one of the following)​

  • Inflammatory Bowel Disease 

  • GI Woes from Head to Toe 

  • Viral Hepatitis, Cholestatic Disease and Complications of Cirrhosis

  • Alcoholic and Nonalcoholic Fatty Liver Disease

​

12:00 PM – 1:00 PM

Lunch Product Theater (Non-Accredited)

Taking Current PBC Treatment Further

Sponsored by: Intercept Pharmaceuticals, Inc.

​

SESSION IV (Razvan Arsenescu, MD, PhD)

​

1:00 – 1:25 PM

Selecting Therapy Based on Prognosis in Ulcerative Colitis and Crohn’s Disease

Gary Lichtenstein, MD

​

1:25 – 1:50 PM

Practical Applications of Treat to Target in Inflammatory Bowel Disease (IBD)

Stephen Hanauer, MD

​

1:50 – 2:15 PM

Managing Post-operative Crohn’s Disease

David Binion, MD

​

2:15 – 2:40 PM

Applying Dietary Interventions in Inflammatory Bowel Disease (IBD)

Razvan Arsenescu, MD, PhD*

​

2:40 – 3:05 PM

Q&A / Panel Discussion

​

3:05 – 3:20 PM

Break

​

SESSION V (Nikolaos Pyrsopoulos, MD, PhD, MBA)

​

3:20 – 3:50 PM

Primary Biliary Cholangitis (PBC) and Primary Sclerosing Cholangitis (PSC): Diagnosis and Treatment

Nikolaos Pyrsopoulos, MD, PhD, MBA*

​

3:50 – 4:20 PM

Hepatocellular Carcinoma: Diagnosis and Treatment

Hashem El-Serag, MD, MPH

​

4:20 – 4:40 PM

Q&A/Panel Discussion

​

4:40 – 4:45 PM

Meeting Wrap-up

​

​

*Onsite faculty at Crystal Springs.

  • Facebook Social Icon
  • Twitter Social Icon

This activity is supported by educational grants from AbbVie, Allergan Inc.,

Dova Pharmaceuticals, Gilead, Intercept Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Salix Pharmaceuticals and Takeda Pharmaceuticals U.S.A., Inc.

ACHS_New_Logo_4L.png

Jointly provided by the Annenberg Center for Health Sciences 
at Eisenhower, the Gastrointestinal and Liver Association of the Americas (GALA), and the Texas Liver Institute.

TLI.png

© 2020 GI and Liver Association of the Americas

bottom of page